Associate Director, GMP Quality Assurance

Revolution Medicines•Redwood City, CA

8d•$186,000 - $233,000•Onsite

About The Position

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, GMP Quality Assurance will provide quality oversight and decision-making authority for development, technology transfe , manufacture, testing, and batch disposition of small molecule Drug Substance (DS) and Drug Product Intermediate (DPI). The role ensures GMP compliance, product quality, data integrity, and inspection readiness for late-stage clinical and commercial programs. This role will be the primary Quality partner to Technical Operations, CMC, Regulatory, Supply Chain, Analytical Development, and external CDMOs, with end-to-end oversight of DS and DPI manufacturing, quality events, validation, and continuous improvement.

Requirements

A Bachelor's degree in a scientific or technical discipline is required.
A minimum of 10+ years of progressive GMP Quality experience, including late-stage or commercial small molecule DS and/or DPI manufacturing.
Quality oversight of CDMOs supporting technology transfer, validation/PPQ, manufacturing, testing, and batch release.
Inspection readiness experience in the United States and ex-US markets.
Technical knowledge of small molecule process chemistry, process controls, impurity management, analytical testing, specifications, and validation.
Knowledge of applicable US and global GMP regulations and industry practices.
Experience with deviations, investigations, OOS/OOT, CAPAs, change controls, and risk assessments.
Ability to assess complex manufacturing and analytical issues and make risk-based Quality decisions.
Strong leadership, collaboration, and stakeholder management skills.
Ability to manage multiple priorities, external partners, and aggressive timelines.
Sound judgment, attention to detail, self-motivation, and commitment to product quality.
Proficiency with Microsoft Office and electronic quality/document management systems.
Experience reviewing CMC content for IND/IMPD/NDA submissions and post-approval changes.

Nice To Haves

Commercial DS/DPI disposition and post-approval change experience is preferred.

Responsibilities

Provide QA oversight and disposition support for clinical and commercial small molecule DS and DPI batches, ensuring compliance with GMPs, regulatory filings, specifications, and internal standards.
Review and approve master and executed batch records, specifications, methods, certificates of analysis, and release packages.
Review and approve deviations, investigations, OOS/OOT results, change controls, CAPAs, and risk assessments affecting DS and DPI; ensure scientifically sound product-impact evaluations.
Lead Quality Governance and operational meetings with CDMOs and contract laboratories to align on manufacturing readiness, issue escalation, release timelines, and performance.
Provide QA oversight for technology transfer, scale-up, process validation/PPQ, cleaning validation, analytical method transfer, and continued process verification.
Support CMC submissions, inspections, lifecycle changes, and health authority responses.
Maintain inspection readiness and the GMP Quality System through SOPs, supplier qualification, metrics, and oversight of critical materials, CDMOs, and laboratories.